1. Home
  2. VKTX vs CPA Comparison

VKTX vs CPA Comparison

Compare VKTX & CPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • CPA
  • Stock Information
  • Founded
  • VKTX 2012
  • CPA 1947
  • Country
  • VKTX United States
  • CPA Panama
  • Employees
  • VKTX N/A
  • CPA N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • CPA Air Freight/Delivery Services
  • Sector
  • VKTX Health Care
  • CPA Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • CPA Nasdaq
  • Market Cap
  • VKTX 3.4B
  • CPA 3.9B
  • IPO Year
  • VKTX 2015
  • CPA 2005
  • Fundamental
  • Price
  • VKTX $23.94
  • CPA $88.14
  • Analyst Decision
  • VKTX Strong Buy
  • CPA Strong Buy
  • Analyst Count
  • VKTX 12
  • CPA 7
  • Target Price
  • VKTX $89.75
  • CPA $156.14
  • AVG Volume (30 Days)
  • VKTX 4.5M
  • CPA 315.4K
  • Earning Date
  • VKTX 04-23-2025
  • CPA 05-07-2025
  • Dividend Yield
  • VKTX N/A
  • CPA 7.30%
  • EPS Growth
  • VKTX N/A
  • CPA 13.93
  • EPS
  • VKTX N/A
  • CPA 14.56
  • Revenue
  • VKTX N/A
  • CPA $3,444,630,000.00
  • Revenue This Year
  • VKTX N/A
  • CPA $7.09
  • Revenue Next Year
  • VKTX N/A
  • CPA $8.70
  • P/E Ratio
  • VKTX N/A
  • CPA $6.05
  • Revenue Growth
  • VKTX N/A
  • CPA N/A
  • 52 Week Low
  • VKTX $18.92
  • CPA $80.01
  • 52 Week High
  • VKTX $81.86
  • CPA $114.00
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 46.06
  • CPA 45.67
  • Support Level
  • VKTX $18.92
  • CPA $87.23
  • Resistance Level
  • VKTX $27.09
  • CPA $90.77
  • Average True Range (ATR)
  • VKTX 2.31
  • CPA 4.00
  • MACD
  • VKTX 0.26
  • CPA -0.02
  • Stochastic Oscillator
  • VKTX 61.44
  • CPA 51.80

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About CPA Copa Holdings S.A.

Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama and domestic and international air transportation for passengers, cargo and mail with a point-to-point route network through Copa Colombia a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.

Share on Social Networks: